PALOMA ARAGONCILLO BALLESTEROS-rekin lankidetzan egindako argitalpenak (6)

2013

  1. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure

    Journal of Hypertension, Vol. 31, Núm. 11, pp. 2309-2319

2010

  1. Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction

    European Journal of Heart Failure, Vol. 12, Núm. 9, pp. 903-912

2009

  1. Atheromatous plaque from human carotid artery: Potential involvement of the endothelin-1 and their receptors

    Process Biochemistry, Vol. 44, Núm. 11, pp. 1231-1236

  2. Characterization and localization of the endothelin receptors in human end-stage heart failure. ETA/ETB receptor system-Role in the failing human heart

    Process Biochemistry, Vol. 44, Núm. 6, pp. 661-667

  3. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect

    British Journal of Pharmacology, Vol. 156, Núm. 8, pp. 1218-1227

2006

  1. Activation of peroxisome proliferator-activated receptor-α and -γ In auricular tissue from heart failure patients

    European Journal of Heart Failure, Vol. 8, Núm. 2, pp. 154-161